ACADIA Pharmaceuticals Inc (ACAD)
16.18
-0.09
(-0.55%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
+0.02
(+0.09%)
After-Hours: 20:00
ACADIA Pharmaceuticals Max Drawdown (5Y): 77.18% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 77.18% |
| September 30, 2024 | 77.18% |
| August 31, 2024 | 77.18% |
| July 31, 2024 | 77.18% |
| June 30, 2024 | 77.18% |
| May 31, 2024 | 77.18% |
| April 30, 2024 | 77.18% |
| March 31, 2024 | 77.18% |
| February 29, 2024 | 77.18% |
| January 31, 2024 | 77.18% |
| December 31, 2023 | 77.18% |
| November 30, 2023 | 77.18% |
| October 31, 2023 | 77.18% |
| September 30, 2023 | 77.18% |
| August 31, 2023 | 77.18% |
| July 31, 2023 | 77.18% |
| June 30, 2023 | 77.18% |
| May 31, 2023 | 77.18% |
| April 30, 2023 | 77.18% |
| March 31, 2023 | 77.18% |
| February 28, 2023 | 77.18% |
| January 31, 2023 | 77.18% |
| December 31, 2022 | 77.18% |
| November 30, 2022 | 77.18% |
| October 31, 2022 | 77.18% |
| Date | Value |
|---|---|
| September 30, 2022 | 77.18% |
| August 31, 2022 | 77.18% |
| July 31, 2022 | 77.18% |
| June 30, 2022 | 77.18% |
| May 31, 2022 | 73.99% |
| April 30, 2022 | 73.99% |
| March 31, 2022 | 73.99% |
| February 28, 2022 | 73.99% |
| January 31, 2022 | 73.99% |
| December 31, 2021 | 73.99% |
| November 30, 2021 | 73.99% |
| October 31, 2021 | 73.99% |
| September 30, 2021 | 73.99% |
| August 31, 2021 | 73.99% |
| July 31, 2021 | 73.99% |
| June 30, 2021 | 73.99% |
| May 31, 2021 | 73.99% |
| April 30, 2021 | 73.99% |
| March 31, 2021 | 73.99% |
| February 28, 2021 | 73.99% |
| January 31, 2021 | 73.99% |
| December 31, 2020 | 73.99% |
| November 30, 2020 | 73.99% |
| October 31, 2020 | 73.99% |
| September 30, 2020 | 73.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.99%
Minimum
Nov 2019
77.18%
Maximum
Jun 2022
75.53%
Average
73.99%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Bristol-Myers Squibb Co | 47.67% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.48 |
| Beta (5Y) | 0.3796 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.36% |
| Historical Sharpe Ratio (5Y) | -0.3898 |
| Historical Sortino (5Y) | -0.5975 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.53% |